GOP Rep. Collins' son and son's fiancee bought stock days before getting tip on drug trial, SEC says

Chris Collins' son Cameron Collins and his accountant fiancee Lauren Zarsky had purchased the stock of Innate Immunotherapeutics in June 2017 because they believed — mistakenly it turned out — that the trial for the company's multiple sclerosis treatment would yield positive results, the SEC said in its complaint.